Fineline Cube

Follow:
14486 Articles
Bristol-Myers Squibb's Opdivo Qvantig Receives FDA Approval for Expanded Indications
CompanyDrug

Bristol-Myers Squibb’s Opdivo Qvantig Receives FDA Approval for Expanded Indications

HitGen Inc. Initiates Phase II Clinical Trial for HG146 in Adenoid Cystic Carcinoma
CompanyDrug

HitGen Inc. Initiates Phase II Clinical Trial for HG146 in Adenoid Cystic Carcinoma

Reforgene Medicine Secures Hundreds of Millions in Financing for Gene Therapy Expansion
CompanyDeals

Reforgene Medicine Secures Hundreds of Millions in Financing for Gene Therapy Expansion

Xtalpi Inc. Partners with NCCS and Duke-NUS to Advance AI-Driven Drug Discovery
CompanyDeals

Xtalpi Inc. Partners with NCCS and Duke-NUS to Advance AI-Driven Drug Discovery

Danaher Corporation Opens Joint Office in Beijing's Chaoyang District
Company

Danaher Corporation Opens Joint Office in Beijing’s Chaoyang District

WuXi Biologics Partners with Sino Biopharmaceutical for First-in-Class Monoclonal Antibody Development
CompanyDeals

WuXi Biologics Partners with Sino Biopharmaceutical for First-in-Class Monoclonal Antibody Development

Hainan Free Trade Port Gets Green Light for Temporary Import of Special Medical Foods
Policy / Regulatory

Hainan Free Trade Port Gets Green Light for Temporary Import of Special Medical Foods

GenFleet Therapeutics Submits IPO Application to HKEX, Backed by CITIC Securities
Company

GenFleet Therapeutics Submits IPO Application to HKEX, Backed by CITIC Securities

Overwhelming Shareholder Support for Hengrui Pharmaceuticals' H-Share IPO
Company

Overwhelming Shareholder Support for Hengrui Pharmaceuticals’ H-Share IPO

Dynamiker Biotechnology Receives Approval for IPO on Beijing Stock Exchange
Company

Dynamiker Biotechnology Receives Approval for IPO on Beijing Stock Exchange

MicroPort Endovascular MedTech's Castor® Branched Stent Wins China Patent Gold Award
Company

MicroPort Endovascular MedTech’s Castor® Branched Stent Wins China Patent Gold Award

Daiichi Sankyo and AstraZeneca Withdraw EU Application for Datopotamab Deruxtecan in Lung Cancer
CompanyDrug

Daiichi Sankyo and AstraZeneca Withdraw EU Application for Datopotamab Deruxtecan in Lung Cancer